Do heart rhythm drugs pose risks in hospital?
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This study looks at whether certain medications that can affect heart rhythm (QT-prolonging drugs) are linked to serious heart problems in adults who were hospitalized. It includes patients admitted to St. Joseph's Healthcare Hamilton or other GEMINI hospitals between 2017 and 2025.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been admitted to St. Joseph's Healthcare Hamilton or a GEMINI hospital as an inpatient (not just an outpatient visit).
- Your hospital stay must have happened between December 2017 and March 2025.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks a more detailed kind of heart recording (ECG) using many small sensors to better measure electrical rhythm problems. It may help doctors refine how they assess risk in people with serious or suspected dangerous heart rhythm issues.
This study is for children and teens in a hospital psychiatric ward who are starting a new medicine that might affect their heart's rhythm. It will check your heart with an ECG (electrocardiogram) to make sure it stays safe.
This study looks at how often people coming to the emergency room with a certain type of heart attack (non-ST elevation) have serious problems with their heart rhythm. The goal is to understand which patients need extra monitoring.
This study looks at dangerous heart rhythms that happen during a heart attack. Researchers will review medical records from 2012–2024 to understand these rhythms better and potentially improve treatment.
This study looks at people hospitalized for a heart muscle inflammation called myocarditis. It aims to better understand the risk of heart rhythm problems, which could help guide future care.
This study watches people who are hospitalized for an irregular heartbeat. It aims to collect information to better understand and manage arrhythmias. No new treatments or medicines are tested.
Hear when a new Syncope trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.